+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopharma Perceptions of Global CRO Thought Leadership - 2023

  • PDF Icon

    Report

  • 60 Pages
  • June 2023
  • Region: Global
  • Life Science Strategy Group, LLC
  • ID: 5822703

This report takes a deep dive into Biopharma’s perceptions of thought leadership of global contract research organizations (CROs), providing first-of-its-kind insights into importance of current industry thought leadership topics, elements of thought leadership value, methods CROs can use to communicate thought leadership and preferred channels for thought leadership dissemination. 

The report also details perceptions of leading CROs’ thought leadership and includes benchmark data and analysis for IQVIA, Parexel, PPD/Thermo Fisher Scientific, ICON/PRA, Labcorp/Covance, Syneos Health and Medpace. This highly strategic research should be considered foundational information for biopharma and CRO industry professionals, industry analysts and investors competing and following the evolving market.

Overview

The report examines perceptions of 120 professionals across emerging, small, mid-size and large biopharmaceutical companies in North America and Europe involved in outsourcing clinical development services to the leading, global CROs. 

Topics covered include:

  • Interest in thought leadership topics
  • Importance of thought leadership aspects
  • Biopharma perceptions of CRO thought leadership 
  • IQVIA
  • Parexel
  • PPD/Thermo Fisher Scientific
  • ICON/PRA
  • Labcorp/Covance
  • Syneos Health
  • Medpace
  • Best methods to communicate thought leadership
  • Preferred channels to communicate thought leadership

Table of Contents

I. Study Background

II. Executive Summary  

III. Methodology  

IV. Detailed Findings  

V. Respondent Demographics  

VI. About the Publisher

List of Figures

  • Interest in Thought Leadership Topics
  • Importance of Thought Leadership Aspects 
  • ICON/PRA Thought Leadership Strength
  • IQVIA Thought Leadership Strength
  • Labcorp/Covance Thought Leadership Strength
  • Medpace Thought Leadership Strength
  • Parexel Thought Leadership Strength
  • PPD/Thermo Fisher Thought Leadership Strength
  • Syneos Health Thought Leadership Strength
  • CRO Thought Leader Positioning (Trial Design and  Conduct)
  • CRO Thought Leader Positioning (Functional Expertise)
  • CRO Thought Leader Positioning (Technology and AI)
  • Interest in Thought Leadership Topics Ranked
  • Importance of Thought Leadership Aspects Ranked
  • Best Ways to Establish Thought Leadership Ranked
  • CRO Communication Channels for Thought Leadership Ranked
  • Perceived CRO Thought Leaders for Innovative Trial Design 
  • Perceived CRO Thought Leaders for Translation Medicine 
  • Perceived CRO Thought Leaders for Clinical Trial Patient Recruitment
  • Perceived CRO Thought Leaders for Understanding the changing regulatory environment to accelerate drug approval
  • Perceived CRO Thought Leaders for Real-World Data and generating Real-World Evidence to support drug development)
  • Perceived CRO Thought Leaders for DCT strategies to improve participation, diversity, engagement and retention in clinical trials
  • Perceived CRO Thought Leaders for Patient-Centric Approaches to Clinical Development
  • Perceived CRO Thought Leaders for Digital technologies in drug development to expand data collection
  • Perceived CRO Thought Leaders for Innovative partnering and outsourcing models/approaches
  • Perceived CRO Thought Leaders for The role and application of (AI) and natural/learning language models to drug development
  • Respondent Demographics

Samples

Loading
LOADING...

Companies Mentioned

  • Covance
  • ICON
  • IQVIA
  • Labcorp
  • Medpace
  • Parexel
  • PPD
  • PRA
  • Syneos Health
  • Thermo Fisher Scientific